{
  "title": "Paper_921",
  "abstract": "pmc Vaccines (Basel) Vaccines (Basel) 2764 vaccines vaccines Vaccines 2076-393X Multidisciplinary Digital Publishing Institute  (MDPI) PMC12474269 PMC12474269.1 12474269 12474269 41012147 10.3390/vaccines13090943 vaccines-13-00943 1 Article CXCR5 Signals Fine-Tune Dendritic Cell Transcription and Regulate T H https://orcid.org/0000-0001-5118-2279 Curtiss Miranda L. Conceptualization Methodology Validation Formal analysis Investigation Resources Writing – original draft Visualization Supervision Funding acquisition 1 * Benavides Natalia Ballesteros Investigation 2 Rosenberg Alexander F. Methodology Software Formal analysis Investigation Data curation Writing – original draft Visualization 3 https://orcid.org/0000-0001-7716-8504 Scharer Christopher D. Methodology Software Validation Formal analysis Data curation Writing – original draft 4 https://orcid.org/0000-0002-3793-3854 León Beatriz 2 5 https://orcid.org/0000-0003-3083-1246 Lund Frances E. Conceptualization Resources Writing – original draft Supervision Project administration Funding acquisition 2 Bardi Giuseppe Academic Editor 1 2 beatriz.leonruiz@nih.gov flund@uab.edu 3 afr@uab.edu 4 cdschar@emory.edu 5 * mlcurtiss@uabmc.edu 03 9 2025 9 2025 13 9 497676 943 16 7 2025 19 8 2025 29 8 2025 03 09 2025 28 09 2025 29 09 2025 © 2025 by the authors. 2025 https://creativecommons.org/licenses/by/4.0/ Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( https://creativecommons.org/licenses/by/4.0/ Background/Objectives: We previously demonstrated that dendritic cell (DC) expression of CXCR5 is required for T H Heligmosomoides polygyrus (Hp) H in vitro H in vivo Hp H Cxcr5 H in vitro H in vitro H Cxcr5 −/− Hp Hp Chitinase 3-like-1 (Chi3l1) H in vitro H H Chi3l1 H in vivo Hp Chi3l1 H dendritic cells T H CXCR5 Chi3l1 helminth infection National Institutes of Health (NIH) NIH/NIAID 1R01AI104725 UAB Frommeyer Investigative Fellowship UAB Dixon Award AAAAI/ALA Allergic Respiratory Disease Research Award 699115 Funding from National Cancer Institute (NCI) P30 CA013148 Center for AIDS Research P30 AI027767 Research reported in this manuscript was supported by grants from the National Institutes of Health (NIH): NIH/NIAID 1R01AI104725 (F.E.L.). M.LC. was supported by the UAB Frommeyer Investigative Fellowship, UAB Dixon Award, and AAAAI/ALA Allergic Respiratory Disease Research Award: 699115 (M.L.C.). Funding from National Cancer Institute (NCI) P30 CA013148 supports the UAB Flow Cytometry and Single Cell Services Core. The UAB Flow Cytometry and Single Cell Services Core is further supported by the Center for AIDS Research (P30 AI027767). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes 1. Introduction Dendritic cells (DCs) are professional antigen-presenting cells that can take up antigen, process antigen and display peptides from the processed antigen to CD4 and CD8 T cells to facilitate T cell activation or, in some settings, T cell tolerance [ 1 H 2 H 1 2 3 hi + + hi 2 neg + + neg 4 5 + + neg neg 1 6 7 8 9 10 H 5 7 11 12 1 13 11 14 8 15 16 Murine models of helminth infection reveal important roles for the cDC2 subset during T H Heligmosomoides polygyrus (Hp) Batf3 −/− 15 17 H Hp 8 Batf3 −/− H 1 Leishmania major 9 Irf4 H Nippostrongylus brasiliensis (Nb) 14 14 18 Klf4 in vivo H Schistosoma mansonii 7 In vitro H Hp in vitro, H 19 Nb H in vivo 20 H Prior work from multiple labs [ 3 21 22 23 24 25 3 21 22 23 Hp 3 + 24 25 Cxcr5 + Hp 3 Trichuris muris 22 H Our prior data showed that expression of CXCR5 by both DCs and CD4 T cells is important for the development of a robust T H Hp 3 H H in vitro H Cxcr5 −/− Cxcr5 in vitro H H Hp Cxcr5 −/− Chi3l1 H 26 in vitro H H Chi3l1 H Hp H Chi3l1 H 2. Materials and Methods 2.1. Mice All experimental animals were bred and maintained in the University of Alabama at Birmingham (UAB) animal facilities. All procedures involving animals were approved by the UAB Institutional Animal Care and Use Committee and were conducted in accordance with the principles outlined by the National Research Council. CD45.2 + + a b + 27 28 Cxcr5 tm1Lipp Cxcr5 −/− 29 Tg 30 31 Tg(Itgax-DTR/EGFP)57Lan Tg/− 32 a +/+ 33 Chi3l1 −/− 26 Tg/− +/+ Tg/− +/+ + Tg Tg/− Tg/− + Tg/− +/+ Tg Tg/− +/− Tg +/+ Tg/Tg Tg/Tg Tg tm1Lky CD11c-Cxcr5 Tg Cxcr5 2.2. Bone Marrow Chimeras Bone marrow (BM) chimeric mice were generated by irradiating BALB/c or B6 CD45.1 + 6 Chi3l1 6 Tg/− +/+ 6 6 Tg/− +/+ 6 Chi3l1 −/− Chi3l1 −/− Cxcr5 −/− + 6 + 6 Cxcr5 −/− 2.3. Infections and Diphtheria Toxin Treatment H polygyrus (Hp) 3 34 H polygyrus i.p. Hp 2.4. Flow Cytometry Mice were sacrificed at 8 or 14 days post-infection ( p.i. Hp 4 3 ® To determine the number and phenotypic characteristics of the DCs, msLNs of uninfected and Hp To detect intracellular cytokines, msLN cells were restimulated with 2.5 μg/mL plate-bound anti-CD3 (145-2C11, BioXCell) in the presence of 12.5 μg/mL brefeldin A (Sigma) for 4 h, blocked with Fc block (2.4G2 BioXCell), and then surface stained (CD4, CD44, Thy1.1 and Thy1.2). After washing, the cells were fixed in formalin, permeabilized with 0.1% NP-40, washed, incubated with the anti-cytokine antibodies IL-4 (11B11, BD and Invitrogen, Waltham, MA, USA) and IL-13 (eBio13A, eBioscience) in permeabilization buffer and washed. All incubations prior to fixation were performed in the presence of brefeldin A. All flow analysis was performed on a BD Canto. 2.5. DC Enrichment and Sort Purification For RNA-seq, chimeras were generated from B6 Pepboy CD45.1 + + Cxcr5 −/− + Cxcr5 −/− p.i. Hp + hi − + + Cxcr5 −/− + − − + To assess the capacity of msLN migratory DCs to initiate T H in vitro p.i. Hp Cxcr5 −/− + hi − + + Cxcr5 −/− CD11c-Cxcr5 Tg + hi − + + + 2.6. In Vitro T H Spleen cells were isolated from naive OT-II.4get mice and CD4 T cells were positively selected using Miltenyi L3T4 beads. DCs were enriched from the msLN of D8 Hp + 5 4 (323–339) H In other experiments, recombinant Chi3l1 was tested in the in vitro H Hp Cxcr5 −/− p.i. + 5 4 (323–339) OT-II.4get transgenic CD4 + + − + TM 2.7. DC Chemotaxis Assay DCs were positively selected with Miltenyi CD11c beads from spleens isolated from uninfected Cxcr5 −/− CD11c Cxcr5 Tg 2.8. Bulk RNA-Seq Analysis RNA was isolated (RNeasy micro column (Qiagen, Germantown, MD, USA)) from sorted msLN migratory DCs of Hp Cxcr5 −/− 35 + + Cxcr5 −/− + − − + 36 37 http://broadinstitute.github.io/picard 38 Table S1 Cxcr5 −/− Cxcr5 −/− 39 2 Cxcr5 −/− Cxcr5 −/− Table S1 40 Table S2 http://software.broadinstitute.org/gsea/index.jsp Cxcr5 −/− 10 p Cxcr5 −/− Table S1 Table S3 Table S4 2.9. Statistical Analysis Statistical details of all experiments including tests used, n, and number of experimental repeats are provided in figure legends. FlowJo (version 9, Tree Star) was used for flow cytometric analyses. Prism Graphpad (version 10.1) was used for statistical analyses and graphing except where indicated. Details of transcriptomics statistical analyses are provided above. 3. Results 3.1. T H Our prior in vivo H H. polygyrus Hp 3 + H FH 3 25 H + Cxcr5 Cxcr5 −/− H in vitro H in vitro Cxcr5 Cxcr5 −/− 29 + + + Cxcr5 −/− + Cxcr5 −/− Figure 1 Hp p.i. + + Cxcr5 −/− + hi Figure 1 + 41 Figure 1 + Cxcr5 −/− H Figure 1 H Figure 1 H H + Cxcr5 −/− Figure 1 H 3.2. CXCR5 Is Expressed by Migratory cDC2 and Not cDC1 Cells Our results indicated that Cxcr5 Hp 3 H + hi + − − + + + − − 7 8 9 10 + H in vitro 19 21 + − Hp Hp p.i. + Figure 2 Figure 2 Hp Figure 2 Figure 2 + − + Figure 2 H 14 18 19 20 H 3.3. Enforced CXCR5 Expression by Migratory CD11b + H Since CXCR5 expression by migratory DCs regulated the capacity of these cells to induce T H in vitro neg + H + Figure S1A Cxcr5 Tg CD11c-Cxcr5 Tg Figure S1B + Cxcr5 42 + Figure 3 + CD11c-Cxcr5 Tg Figure 3 + Figure 3 + Figure 3 Cxcr5 −/− Cxcr5 −/− Figure 3 CD11c-Cxcr5 Tg Although we anticipated that all the CD11c + Figure 3 Hp CD11c-Cxcr5 Tg + int neg Figure S1C CD11c-Cxcr5 Tg Figure S1D Figure S1D Figure 3 Hp + hi neg CD11c-Cxcr5 Tg Figure S1E,F Figure S1E,F Figure 3 + Figure S1E,F Figure 3 Since the CXCR5 transgene could not be detected in the CD103 + − H + CD11c-Cxcr5 Tg Figure 3 Figure 2 + H in vitro + + Figure S1G Hp CD11c-Cxcr5 Tg + + + CD11c-Cxcr5 Tg Figure 3 + H Cxcr5 H 3.4. CXCR5 Regulates Cell Division Pathways and Modulates the Size of the Migratory cDC2 Compartment Although we previously speculated that CXCR5 expressed by migratory DCs simply ensured co-localization of these DCs with the CXCR5-expressing CD4 T cells that are endowed with the potential to differentiate into T H FH 3 in vitro H H + + Cxcr5 −/− neg + + neg Hp Cxcr5 −/− Figure S2 p 2 Table S1 Cxcr5 −/− Figure 4 Cxcr5 −/− Figure 4 Cxcr5 −/− Figure 4 + 40 Cxcr5 −/− Table S2 Figure 4 Figure 4 Cxcr5 −/− Table S1 Cxcr5 −/− Cxcr5 −/− Figure 4 Table S3 43 44 Cxcr5 −/− Figure 4 Table S4 Ccna2, Ccnb2 Top2a, Kif20a Nuf2 Cxcr5 −/− Cxcr5 −/− Tables S3 and S4 Cxcr5 −/− To address whether CXCR5 expression by cDC2 cells influenced the size of the cDC2 population in the msLN during Hp Hp Cxcr5 −/− + + Figure S2A–C + Cxcr5 −/− Figure S2D,E Cxcr5 −/− Figure 4 Figure 4 t + Cxcr5 −/− Figure 4 Figure 4 + Cxcr5 −/− Figure S2F–M Hp Cxcr5 −/− Cxcr5 −/− 3.5. Chi3l1, a CXCR5-Regulated Gene in cDC2 Cells, Supports T H Our data showed that Cxcr5 Hp Figure 4 Hp Cxcr5 −/− H in vitro Figure 1 H Chi3l1 26 2 −48 Cxcr5 −/− Figure 4 Chi3l1 Cxcr5 −/− Cxcr5 −/− Figure 5 Chi3l1 To determine whether soluble Chi3l1 protein could enhance T H + Hp H in vitro Figure 5 H Cxcr5 −/− in trans in vitro + Cxcr5 −/− H Cxcr5 −/− Figure 5 Hp H in vitro H Cxcr5 −/− in vitro H 3.6. Chi3l1 Regulates the Size of the msLN cDC2 Population Following Hp Infection Given that Chi3l1 Cxcr5 Hp H in vitro H in vivo Hp Chi3l1 −/− + hi Chi3l1 −/− Chi3l1 −/− Hp Figure S4A,B Figure S4C + − Figure 5 Figure 5 Hp Chi3l1 −/− Chi3l1 −/− Figure 5 Hp Chi3l1 −/− Figure S4D–G Cxcr5 Chi3l1 Hp 3.7. DC-Intrinsic Expression of Chi3l1 Regulates T H Prior experiments from our group showed that the number of IL-4 + + H Hp Chi3l1 −/− Chi3l1 + + H 45 Hp Chi3l1 45 Chi3l1 H in vitro in vivo 14 18 19 20 Chi3l1 H Hp + neg Chi3l1 −/− neg Figure 6 Hp Chi3l1 −/− Chi3l1 −/− Hp Figure 6 + Chi3l1 Figure 6 + Chi3l1 −/− + Chi3l1 −/− Figure 6 Chi3l1 Hp + hi + Chi3l1 −/− Figure 6 in vitro Chi3l1 H Hp These data show that expression of CXCR5 by migratory CD11b + H H H H H 4. Discussion More than a decade ago, we reported that CXCR5 expression by DCs promotes T H Hp 3 1 2 + + 21 25 46 Il12a Il12b Ccr7 Hp Table S1 H 5 7 11 12 H H H + H Cxcr5 Il12a Il12b H Cxcr5 −/− H in vitro + in vitro H H To better understand what pathways or molecules enhance the T H + Cxcr5 −/− Hp Cxcr5 −/− Cxcr5 −/− H Hp 47 Cxcr5 −/− Chi3l1 Cxcr5 −/− CHI3L1 CHI3L1 48 49 50 51 52 53 54 Chi3l1 −/− 26 50 52 54 55 56 57 Chi3l1 −/− Hp 45 Chi3l1 H Chi3l1 H Hp Chi3l1 H in vitro 58 H in vitro H Chi3l1 H in vivo Chi3l1 + H Upregulation of Chi3l1 Hp Cxcr5 −/− H in vitro H Cxcr5 Chi3l1 + − − − 7 8 9 10 Cxcr5 −/− Cxcr5 −/− Cxcr5 −/− + − Cxcr5 −/− Cxcr5 −/− Il12 59 60 61 62 H 44 63 64 65 66 60 67 68 69 2 70 H 70 H 5. Conclusions Taken together, the data presented here support the conclusion that the CXCR5 is expressed by migratory DCs within the cDC2 compartment that responds to intestinal helminth infection by supporting development of the protective T H H in vitro in vivo Chi3l1 H in vitro in vivo + H Hp H + H FH Acknowledgments We acknowledge Scott Simpler, Rebecca Burnham, Uma Mudunuru and Dakota Finley for mouse colony support, Troy D. Randall for supervision of staff associated with this project, Amit Gaggar for supervision of staff and critical reading of drafts and revisions of this manuscript, and Robert Kesterson and the UAB transgenic core for generation of the CXCR5 transgenic mouse model. Disclaimer/Publisher’s Note: Supplementary Materials The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vaccines13090943/s1 + + Cxcr5 Hp Chi3l1 Hp Hp Cxcr5 −/− Cxcr5 −/− Hp Cxcr5 −/− Hp Cxcr5 −/− Hp Author Contributions F.E.L. and M.L.C. conceived of the study. F.E.L. secured funding, oversaw project administration, participated in the drafting of the manuscript and its revisions, and provided direct supervision of the overall project. M.L.C. conducted experiments, performed formal analyses, curated data, visualized data, wrote the original draft of the manuscript and participated in its revisions. N.B.B. conducted experiments, and B.L. provided methodological expertise and key reagents. A.F.R. and C.D.S. conducted formal analyses, curated data, and assisted with visualization of the RNA-seq data. All authors have read and agreed to the published version of the manuscript. Institutional Review Board Statement All procedures involving animals were approved by the UAB Institutional Animal Care and Use Committee and were conducted in accordance with the principles outlined by the National Research Council (IACUC-09599, approved 19 December 2022). Data Availability Statement All data reported in this paper will be shared by the lead contact upon request. Bulk RNA-seq data have been deposited at the Gene Expression Omnibus repository (Accession numbers GSE301250) and are publicly available from the date of publication. This paper does not report original code. Conflicts of Interest The authors declare no conflicts of interest. Abbreviations The following abbreviations are used in this manuscript: BM bone marrow CCR7 C-C motif chemokine receptor 7 cDC conventional dendritic cells cDC1 CD11b − cDC2 CD11b+CD103 − Chi3l1 chitinase 3-like-1 gene (mouse protein: Chi3l1, mouse gene Chi3l1 CXCL13 C-X-C motif chemokine ligand 13 CXCR5 C-X-C motif chemokine receptor 5 (mouse protein: CXCR5, mouse gene Cxcr5 DT diphtheria toxin DCs dendritic cells DN CD103 − − DP CD103+CD11b+ conventional DCs EGFP enhanced green fluorescent protein FRCs fibroblastic reticular cells gMFI geometric mean fluorescence intensity GSEA gene set enrichment analysis Hp Heligmosomoides polygyrus IPA Ingenuity Pathway Analysis LN Lymph nodes msLN mesenteric lymph nodes n number of mice Nb Nippostrongylus brasiliensis OVA ovalbumin T H T helper 2 CD4 T cells YKL-40 human protein encoded by CHI3L1 References 1. Ronchese F. Webb G.R. Ochiai S. Lamiable O. Brewerton M. How type-2 dendritic cells induce Th2 differentiation: Instruction, repression, or fostering T cell-T cell communication? Allergy 2025 80 395 407 10.1111/all.16337 39324367 PMC11804308 2. Cabeza-Cabrerizo M. Cardoso A. Minutti C.M. Pereira da Costa M. Reis e Sousa C. Dendritic Cells Revisited Annu. Rev. Immunol. 2021 39 131 166 10.1146/annurev-immunol-061020-053707 33481643 3. Leon B. Ballesteros-Tato A. Browning J.L. Dunn R. Randall T.D. Lund F.E. Regulation of T(H)2 development by CXCR5 + Nat. Immunol. 2012 13 681 690 10.1038/ni.2309 22634865 PMC3548431 4. Stagg A.J. Intestinal Dendritic Cells in Health and Gut Inflammation Front. Immunol. 2018 9 2883 10.3389/fimmu.2018.02883 30574151 PMC6291504 5. Connor L.M. Tang S.C. Cognard E. Ochiai S. Hilligan K.L. Old S.I. Pellefigues C. White R.F. Patel D. Smith A.A. Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles J. Exp. Med. 2017 214 125 142 10.1084/jem.20160470 27913566 PMC5206495 6. Sasaki I. Kato T. Hemmi H. Fukuda-Ohta Y. Wakaki-Nishiyama N. Yamamoto A. Kaisho T. Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis Front. Immunol. 2022 13 857954 10.3389/fimmu.2022.857954 35693801 PMC9184449 7. Tussiwand R. Everts B. Grajales-Reyes G.E. Kretzer N.M. Iwata A. Bagaitkar J. Wu X. Wong R. Anderson D.A. Murphy T.L. Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses Immunity 2015 42 916 928 10.1016/j.immuni.2015.04.017 25992862 PMC4447135 8. Everts B. Tussiwand R. Dreesen L. Fairfax K.C. Huang S.C. Smith A.M. O’Neill C.M. Lam W.Y. Edelson B.T. Urban J.F. Jr. Migratory CD103 + J. Exp. Med. 2016 213 35 51 10.1084/jem.20150235 26712805 PMC4710198 9. Akbari M. Honma K. Kimura D. Miyakoda M. Kimura K. Matsuyama T. Yui K. IRF4 in dendritic cells inhibits IL-12 production and controls Th1 immune responses against Leishmania major J. Immunol. 2014 192 2271 2279 10.4049/jimmunol.1301914 24489086 10. Persson E.K. Uronen-Hansson H. Semmrich M. Rivollier A. Hägerbrand K. Marsal J. Gudjonsson S. Håkansson U. Reizis B. Kotarsky K. IRF4 transcription-factor-dependent CD103 + + Immunity 2013 38 958 969 10.1016/j.immuni.2013.03.009 23664832 11. Mayer J.U. Demiri M. Agace W.W. MacDonald A.S. Svensson-Frej M. Milling S.W. Different populations of CD11b + Nat. Commun. 2017 8 15820 10.1038/ncomms15820 28598427 PMC5472728 12. Plantinga M. Guilliams M. Vanheerswynghels M. Deswarte K. Branco-Madeira F. Toussaint W. Vanhoutte L. Neyt K. Killeen N. Malissen B. Conventional and Monocyte-Derived CD11b + Immunity 2013 38 322 335 10.1016/j.immuni.2012.10.016 23352232 13. Zhang S. Audiger C. Chopin M. Nutt S.L. Transcriptional regulation of dendritic cell development and function Front. Immunol. 2023 14 1182553 10.3389/fimmu.2023.1182553 37520521 PMC10382230 14. Gao Y. Nish S.A. Jiang R. Hou L. Licona-Limon P. Weinstein J.S. Zhao H. Medzhitov R. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells Immunity 2013 39 722 732 10.1016/j.immuni.2013.08.028 24076050 PMC4110745 15. Grajales-Reyes G.E. Iwata A. Albring J. Wu X. Tussiwand R. Kc W. Kretzer N.M. Briseno C.G. Durai V. Bagadia P. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α + Nat. Immunol. 2015 16 708 717 10.1038/ni.3197 26054719 PMC4507574 16. Luda K.M. Joeris T. Persson E.K. Rivollier A. Demiri M. Sitnik K.M. Pool L. Holm J.B. Melo-Gonzalez F. Richter L. IRF8 Transcription-Factor-Dependent Classical Dendritic Cells Are Essential for Intestinal T Cell Homeostasis Immunity 2016 44 860 874 10.1016/j.immuni.2016.02.008 27067057 17. Edelson B.T. Kc W. Juang R. Kohyama M. Benoit L.A. Klekotka P.A. Moon C. Albring J.C. Ise W. Michael D.G. Peripheral CD103 + + J. Exp. Med. 2010 207 823 836 10.1084/jem.20091627 20351058 PMC2856032 18. Williams J.W. Tjota M.Y. Clay B.S. Vander Lugt B. Bandukwala H.S. Hrusch C.L. Decker D.C. Blaine K.M. Fixsen B.R. Singh H. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation Nat. Commun. 2013 4 2990 10.1038/ncomms3990 24356538 PMC4003872 19. Redpath S.A. Heieis G.A. Reynolds L.A. Fonseca N.M. Kim S.S. Perona-Wright G. Functional specialization of intestinal dendritic cell subsets during Th2 helminth infection in mice Eur. J. Immunol. 2018 48 87 98 10.1002/eji.201747073 28960280 20. Connor L.M. Tang S.C. Camberis M. Le Gros G. Ronchese F. Helminth-conditioned dendritic cells prime CD4 + in vivo J. Immunol. 2014 193 2709 2717 10.4049/jimmunol.1400374 25108019 21. Krishnaswamy J.K. Gowthaman U. Zhang B. Mattsson J. Szeponik L. Liu D. Wu R. White T. Calabro S. Xu L. Migratory CD11b + Sci. Immunol. 2017 2 eaam9169 10.1126/sciimmunol.aam9169 29196450 PMC7847246 22. Bradford B.M. Donaldson D.S. Forman R. Else K.J. Mabbott N.A. Increased susceptibility to oral Trichuris muris infection in the specific absence of CXCR5 + + Parasite Immunol. 2018 40 e12566 10.1111/pim.12566 29920694 PMC6099414 23. Brandum E.P. Jorgensen A.S. Rosenkilde M.M. Hjorto G.M. Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer Int. J. Mol. Sci. 2021 22 8340 10.3390/ijms22158340 34361107 PMC8348795 24. Dubey L.K. Ludewig B. Luther S.A. Harris N.L. IL-4Rα-Expressing B Cells Are Required for CXCL13 Production by Fibroblastic Reticular Cells Cell Rep. 2019 27 2442 2458.e2445 10.1016/j.celrep.2019.04.079 31116987 25. Leon B. Lund F.E. Compartmentalization of dendritic cell and T-cell interactions in the lymph node: Anatomy of T-cell fate decisions Immunol. Rev. 2019 289 84 100 10.1111/imr.12758 30977197 PMC6464380 26. Lee C.G. Hartl D. Lee G.R. Koller B. Matsuura H. Da Silva C.A. Sohn M.H. Cohn L. Homer R.J. Kozhich A.A. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis J. Exp. Med. 2009 206 1149 1166 10.1084/jem.20081271 19414556 PMC2715037 27. Shen F.W. Saga Y. Litman G. Freeman G. Tung J.S. Cantor H. Boyse E.A. Cloning of Ly-5 cDNA Proc. Natl. Acad. Sci. USA 1985 82 7360 7363 10.1073/pnas.82.21.7360 3864163 PMC391344 28. Shen F.W. Tung J.S. Boyse E.A. Further definition of the Ly-5 system Immunogenetics 1986 24 146 149 10.1007/BF00364741 3489673 29. Forster R. Mattis A.E. Kremmer E. Wolf E. Brem G. Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen Cell 1996 87 1037 1047 10.1016/S0092-8674(00)81798-5 8978608 30. Barnden M.J. Allison J. Heath W.R. Carbone F.R. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements Immunol. Cell Biol. 1998 76 34 40 10.1046/j.1440-1711.1998.00709.x 9553774 31. Caton M.L. Smith-Raska M.R. Reizis B. Notch-RBP-J signaling controls the homeostasis of CD8-dendritic cells in the spleen J. Exp. Med. 2007 204 1653 1664 10.1084/jem.20062648 17591855 PMC2118632 32. Jung S. Unutmaz D. Wong P. Sano G. De los Santos K. Sparwasser T. Wu S. Vuthoori S. Ko K. Zavala F. In vivo + + Immunity 2002 17 211 220 10.1016/S1074-7613(02)00365-5 12196292 PMC3689299 33. Reif A.E. Allen J.M. Mouse Thymic Iso-antigens Nature 1966 209 521 523 10.1038/209521b0 5919593 34. King I.L. Mohrs M. IL-4-producing CD4 + J. Exp. Med. 2009 206 1001 1007 10.1084/jem.20090313 19380638 PMC2715031 35. Stone S.L. Peel J.N. Scharer C.D. Risley C.A. Chisolm D.A. Schultz M.D. Yu B. Ballesteros-Tato A. Wojciechowski W. Mousseau B. T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-gamma on B Cells Immunity 2019 50 1172 1187.e1177 10.1016/j.immuni.2019.04.004 31076359 PMC6929688 36. Jiang H. Lei R. Ding S.W. Zhu S. Skewer: A fast and accurate adapter trimmer for next-generation sequencing paired-end reads BMC Bioinform. 2014 15 182 10.1186/1471-2105-15-182 PMC4074385 24925680 37. Dobin A. Davis C.A. Schlesinger F. Drenkow J. Zaleski C. Jha S. Batut P. Chaisson M. Gingeras T.R. STAR: Ultrafast universal RNA-seq aligner Bioinformatics 2013 29 15 21 10.1093/bioinformatics/bts635 23104886 PMC3530905 38. Lawrence M. Huber W. Pages H. Aboyoun P. Carlson M. Gentleman R. Morgan M.T. Carey V.J. Software for computing and annotating genomic ranges PLoS Comput. Biol. 2013 9 e1003118 10.1371/journal.pcbi.1003118 23950696 PMC3738458 39. Love M.I. Huber W. Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 Genome Biol. 2014 15 550 10.1186/s13059-014-0550-8 25516281 PMC4302049 40. Subramanian A. Tamayo P. Mootha V.K. Mukherjee S. Ebert B.L. Gillette M.A. Paulovich A. Pomeroy S.L. Golub T.R. Lander E.S. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. USA 2005 102 15545 15550 10.1073/pnas.0506580102 16199517 PMC1239896 41. Mohrs M. Shinkai K. Mohrs K. Locksley R.M. Analysis of type 2 immunity in vivo Immunity 2001 15 303 311 10.1016/S1074-7613(01)00186-8 11520464 42. Rubtsov A.V. Rubtsova K. Fischer A. Meehan R.T. Gillis J.Z. Kappler J.W. Marrack P. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c ⁺ Blood 2011 118 1305 1315 10.1182/blood-2011-01-331462 21543762 PMC3152497 43. Wiese K.E. Walz S. von Eyss B. Wolf E. Athineos D. Sansom O. Eilers M. The role of MIZ-1 in MYC-dependent tumorigenesis Cold Spring Harb. Perspect. Med. 2013 3 a014290 10.1101/cshperspect.a014290 24296348 PMC3839600 44. Ryu S.H. Shin H.S. Eum H.H. Park J.S. Choi W. Na H.Y. In H. Kim T.G. Park S. Hwang S. Granulocyte Macrophage-Colony Stimulating Factor Produces a Splenic Subset of Monocyte-Derived Dendritic Cells That Efficiently Polarize T Helper Type 2 Cells in Response to Blood-Borne Antigen Front. Immunol. 2021 12 767037 10.3389/fimmu.2021.767037 35069539 PMC8778578 45. Curtiss M.L. Rosenberg A.F. Scharer C.D. Mousseau B. Benavides N.A.B. Bradley J.E. León B. Steele C. Randall T.D. Lund F.E. Chitinase-3-like 1 regulates T H FH Front. Immunol. 2023 14 1158493 10.3389/fimmu.2023.1158493 37575256 PMC10415220 46. Eisenbarth S.C. Dendritic cell subsets in T cell programming: Location dictates function Nat. Rev. Immunol. 2019 19 89 103 10.1038/s41577-018-0088-1 30464294 PMC7755085 47. Ansel K.M. Ngo V.N. Hyman P.L. Luther S.A. Forster R. Sedgwick J.D. Browning J.L. Lipp M. Cyster J.G. A chemokine-driven positive feedback loop organizes lymphoid follicles Nature 2000 406 309 314 10.1038/35018581 10917533 48. Acevedo N. Bornacelly A. Mercado D. Unneberg P. Mittermann I. Valenta R. Kennedy M. Scheynius A. Caraballo L. Genetic Variants in CHIA and CHI3L1 Are Associated with the IgE Response to the Ascaris Resistance Marker ABA-1 and the Birch Pollen Allergen Bet v 1 PLoS ONE 2016 11 e0167453 10.1371/journal.pone.0167453 27977724 PMC5157985 49. Kwon J.W. Kim T.W. Cho S.H. Min K.U. Park H.W. Serum YKL-40 levels are correlated with symptom severity in patients with allergic rhinitis Allergy 2011 66 1252 1253 10.1111/j.1398-9995.2011.02596.x 21480926 50. Kim E.G. Kim M.N. Hong J.Y. Lee J.W. Kim S.Y. Kim K.W. Lee C.G. Elias J.A. Song T.W. Sohn M.H. Chitinase 3-Like 1 Contributes to Food Allergy via M2 Macrophage Polarization Allergy Asthma Immunol. Res. 2020 12 1012 1028 10.4168/aair.2020.12.6.1012 32935492 PMC7492506 51. Dezman K. Korosec P. Rupnik H. Rijavec M. SPINK5 is associated with early-onset and CHI3L1 with late-onset atopic dermatitis Int. J. Immunogenet. 2017 44 212 218 10.1111/iji.12327 28681574 52. Lee Y.S. Yu J.E. Kim M.J. Ham H.J. Jeon S.H. Yun J. Song S.G. Lee C.K. Han S.B. Son D.J. New therapeutic strategy for atopic dermatitis by targeting CHI3L1/ITGA5 axis Clin. Transl. Med. 2022 12 e739 10.1002/ctm2.739 35184414 PMC8858621 53. Salomon J. Matusiak L. Nowicka-Suszko D. Szepietowski J.C. Chitinase-3-Like Protein 1 (YKL-40) Reflects the Severity of Symptoms in Atopic Dermatitis J. Immunol. Res. 2017 2017 5746031 10.1155/2017/5746031 28660216 PMC5474268 54. Kwak E.J. Hong J.Y. Kim M.N. Kim S.Y. Kim S.H. Park C.O. Kim K.W. Lee C.G. Elias J.A. Jee H.M. Chitinase 3-like 1 drives allergic skin inflammation via Th2 immunity and M2 macrophage activation Clin. Exp. Allergy 2019 49 1464 1474 10.1111/cea.13478 31397016 55. Mackel J.J. Garth J.M. Jones M. Ellis D.A. Blackburn J.P. Yu Z. Matalon S. Curtiss M. Lund F.E. Hastie A.T. Chitinase 3-like-1 protects airway function despite promoting type 2 inflammation during fungal-associated allergic airway inflammation Am. J. Physiol. Lung Cell. Mol. Physiol. 2021 320 L615 L626 10.1152/ajplung.00528.2020 33533316 PMC8238152 56. Yu J.E. Jeon S.H. Kim M.J. Kim D.H. Koo J.K. Kim T.H. Kim B. Yoon J.Y. Lim Y.S. Park S.R. Anti-chitinase-3-like 1 antibody attenuated atopic dermatitis-like skin inflammation through inhibition of STAT3-dependent CXCL8 expression Br. J. Pharmacol. 2024 181 3232 3245 10.1111/bph.16365 38745399 57. Zhu X. Dai X. Chen W. Li Y. Liu Y. Shan C. Wang J. Meng J. Chi3l1 Knockout Mitigates Chronic Itch and Cutaneous Inflammation in Mice J. Investig. Dermatol. 2025 145 975 979.e974 10.1016/j.jid.2024.09.013 39366519 58. Di Rosa M. Tibullo D. Saccone S. Distefano G. Basile M.S. Di Raimondo F. Malaguarnera L. CHI3L1 nuclear localization in monocyte derived dendritic cells Immunobiology 2016 221 347 356 10.1016/j.imbio.2015.09.023 26466985 59. Do-Umehara H.C. Chen C. Zhang Q. Schleimer R.P. Budinger G.R.S. Liu J. Suppression of Allergic Asthma by Loss of Function of Miz1-mediated Th1 Skewing Am. J. Respir. Cell Mol. Biol. 2022 67 346 359 10.1165/rcmb.2022-0135OC 35833903 PMC9447135 60. Kaliński P. Schuitemaker J.H. Hilkens C.M. Kapsenberg M.L. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a + + J. Immunol. 1998 161 2804 2809 10.4049/jimmunol.161.6.2804 9743339 61. Cuenca-Escalona J. Flórez-Grau G. van den Dries K. Cambi A. de Vries I.J.M. PGE2-EP4 signaling steers cDC2 maturation toward the induction of suppressive T-cell responses Eur. J. Immunol. 2024 54 e2350770 10.1002/eji.202350770 38088451 62. Kaliński P. Hilkens C.M. Snijders A. Snijdewint F.G. Kapsenberg M.L. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells J. Immunol. 1997 159 28 35 10.4049/jimmunol.159.1.28 9200435 63. Jarjour N.N. Bradstreet T.R. Schwarzkopf E.A. Cook M.E. Lai C.-W. Huang S.C.-C. Taneja R. Stappenbeck T.S. Van Dyken S.J. Urban J.F. Jr. BHLHE40 Promotes TH2 Cell–Mediated Antihelminth Immunity and Reveals Cooperative CSF2RB Family Cytokines J. Immunol. 2020 204 923 932 10.4049/jimmunol.1900978 31900338 PMC7002269 64. Kaisar M.M.M. Ritter M. Del Fresno C. Jónasdóttir H.S. van der Ham A.J. Pelgrom L.R. Schramm G. Layland L.E. Sancho D. Prazeres da Costa C. Dectin-1/2-induced autocrine PGE2 signaling licenses dendritic cells to prime Th2 responses PLoS Biol. 2018 16 e2005504 10.1371/journal.pbio.2005504 29668708 PMC5927467 65. Wanzel M. Kleine-Kohlbrecher D. Herold S. Hock A. Berns K. Park J. Hemmings B. Eilers M. Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage Nat. Cell Biol. 2005 7 30 41 10.1038/ncb1202 15580267 66. Peukert K. Staller P. Schneider A. Carmichael G. Hänel F. Eilers M. An alternative pathway for gene regulation by Myc Embo J. 1997 16 5672 5686 10.1093/emboj/16.18.5672 9312026 PMC1170199 67. van de Laar L. Coffer P.J. Woltman A.M. Regulation of dendritic cell development by GM-CSF: Molecular control and implications for immune homeostasis and therapy Blood 2012 119 3383 3393 10.1182/blood-2011-11-370130 22323450 68. Zhan Y. Lew A.M. Chopin M. The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game Front. Immunol. 2019 10–2019 2679 10.3389/fimmu.2019.02679 PMC6873328 31803190 69. Sinha P. Clements V.K. Fulton A.M. Ostrand-Rosenberg S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells Cancer Res. 2007 67 4507 4513 10.1158/0008-5472.CAN-06-4174 17483367 70. Daniel B. Belk J.A. Meier S.L. Chen A.Y. Sandor K. Czimmerer Z. Varga Z. Bene K. Buquicchio F.A. Qi Y. Macrophage inflammatory and regenerative response periodicity is programmed by cell cycle and chromatin state Mol. Cell 2023 83 121 138.e127 10.1016/j.molcel.2022.11.017 36521490 PMC9831293 Figure 1 CXCR5 expression by mLN migratory DCs from Hp H in vitro A C in vitro H Hp + + Cxcr5 −/− + A Cxcr5 −/− Hp + Cxcr5 −/− + + hi B C H H D F − + hi D + + Cxcr5 −/− H E H F t p C https://BioRender.com/ebwsrlb Figure 2 CXCR5 expression by msLN migratory DCs is restricted to the cDC2 compartment following Hp A B Hp Cxcr5 −/− A + B Cxcr5 −/− C H − + hi Hp C D E F G H B D t B D p p Figure 3 Over-expression of CXCR5 by DCs from Hp in vitro H A B Hp CD11c-Cxcr5 Tg Figure S1A,B A + − − − − − − − − B Figure S1C C in vitro 5 CD11c-Cxcr5 Tg Cxcr5 −/− D G Hp CD11c-Cxcr5 Tg D E − + + F + − + − G Figure S1C–F H I H + Hp + + Hp CD11c-Cxcr5 Tg Figure S1G + H I + t p p p Figure 4 CXCR5 expression by msLN cDC2 cells promotes transcriptional proliferation programming and supports increased msLN DC recovery following Hp A F Cxcr5 −/− − + + − Hp Cxcr5 −/− Cxcr5 −/− Figure 1 Hp + Cxcr5 −/− + + − + + Figure S2A,B A B p 2 Cxcr5 −/− A B Table S1 C D Cxcr5 −/− C D Table S2 E F Figure 4 Table S3 Figure 4 Table S4 Table S1 p Cxcr5 −/− 10 p G J + − − − Hp Cxcr5 −/− Figure 1 Cxcr5 −/− Figure S3F–M + Cxcr5 −/− + + − G + + − − I − + J + Cxcr5 −/− + Figure S3F,G Figure S3H,I Figure S3J,K Figure S3L,M A F G J t p p Figure 5 The CXCR5-dependent cDC2 gene product, Chi3l1, enhances T H in vitro Hp A Chi3l1 Cxcr5 −/− Hp Cxcr5 −/− Figure 4 B C H in vitro + + hi Figure S1G Hp + B C + D H Cxcr5 −/− Hp Cxcr5 −/− + E H Chi3l1 −/− Hp Chi3l1 −/− Figure S4A,B − + E − − F + − G + + H Figure S4C Chi3l1 −/− t C E H D p p p p p Figure 6 DC intrinsic expression of Chi3l1 in vivo H Hp A Chi3l1 H in vivo + DTR + + DTR + Chi3l1 −/− + Chi3l1 −/− , Hp i.p. DTR + Chi3l1 −/− Chi3l1 −/− + DTR + Chi3l1 B + + Hp Chi3l1 −/− C D + H Hp Chi3l1 −/− in vitro C + + hi + + hi + + D Chi3l1 −/− t p p ",
  "metadata": {
    "Title of this paper": "Macrophage inflammatory and regenerative response periodicity is programmed by cell cycle and chromatin state",
    "Journal it was published in:": "Vaccines",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12474269/"
  }
}